Vaccination against bubonic and pneumonic plague.

Area of Science:

• Microbiology
• Immunology
• Vaccinology

Background:

• Yersinia pestis causes plague, a disease with a high mortality rate, particularly pneumonic plague.
• Existing vaccines have limitations, including poor efficacy against pneumonic plague or unacceptable virulence.
• Effective plague vaccines are crucial for public health due to ongoing global outbreaks.

Purpose of the Study:

• To review advancements in developing improved plague vaccines.
• To evaluate the efficacy of sub-unit vaccines based on F1 and V antigens.
• To explore novel delivery systems for plague vaccines.

Main Methods:

• Review of scientific literature on plague vaccine development.
• Analysis of studies using F1- and V-antigen sub-unit vaccines in animal models.
• Investigation of microencapsulation and Salmonella-mediated delivery systems for vaccine antigens.

Main Results:

• A sub-unit vaccine comprising F1 and V antigens demonstrates high efficacy against both bubonic and pneumonic plague in animal models.
• Intranasal and oral delivery systems, including microencapsulation and Salmonella delivery, are being explored for sub-unit vaccines.
• These novel approaches aim to enhance vaccine accessibility and effectiveness.

Conclusions:

• Sub-unit vaccines based on F1 and V antigens represent a promising strategy for controlling plague.
• Further research into advanced delivery systems is essential for optimizing vaccine performance and human use.
• Improved vaccines are needed to combat the persistent threat of Yersinia pestis infections.